Cleared Traditional

K770744 - IV SET THAT REVERTS TO KVO RATE

K770744 is an FDA 510(k) clearance for IV SET THAT REVERTS TO KVO RATE, manufactured by Abbott Laboratories. The device is a Class 2 General Hospital device with product code FPA cleared through the Traditional 510(k) pathway after a 34-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
May 1977
Decision
34d
Days
Class 2
Risk

K770744 is an FDA 510(k) clearance for the IV SET THAT REVERTS TO KVO RATE. Classified as Set, Administration, Intravascular (product code FPA), Class II - Special Controls.

Submitted by Abbott Laboratories (Abbott Park, US). The FDA issued a Cleared decision on May 26, 1977 after a review of 34 days - a notably fast clearance cycle.

This device falls under the General Hospital FDA review panel, regulated under 21 CFR 880.5440 - the FDA general hospital device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Abbott Laboratories devices

FDA 510(k) Submission Details - K770744

510(k) Number K770744 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 22, 1977
Decision Date May 26, 1977
Days to Decision 34 days
Submission Type Traditional
Review Panel General Hospital (HO)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
95d faster than avg
Panel avg: 129d · This submission: 34d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

FPA Device Classification - Class 2, Special Controls

Product Code FPA Set, Administration, Intravascular
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 880.5440
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General Hospital devices follow this clearance model.

Regulatory Peers - FPA Set, Administration, Intravascular

All 532
Devices cleared under the same product code (FPA) and FDA review panel - the closest regulatory comparables to K770744.
SURFLO WINGED INFUSION SET
K771204 · Terumo America, Inc. · Jul 1977
SOLUSET FOR IV FAT EMULSION
K770743 · Abbott Laboratories · Jun 1977
BURETTE SET, 2C0132
K770763 · Travenol Laboratories, S.A. · Jun 1977
FILTER, INTRAVENOUS W/AUTO AIR VENT
K770589 · Jelco Laboratories · May 1977
PIGGYBACK VENOSET W/0.22 FILTER
K770518 · Abbott Laboratories · Apr 1977
ERIKA I.V. ADMINISTRATION SET
K770171 · Erika, Inc. · Mar 1977